PAA 3.03% 17.0¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1139

  1. 8,876 Posts.
    lightbulb Created with Sketch. 1715
    Lastly
    Did the phase 2b canine trial meet the main end point (target).
    The answer is no it did not so my statement that it failed to meet its target end point is correct so who are by saying my statement is false
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 16.8¢ $151.1K 877.6K

Buyers (Bids)

No. Vol. Price($)
4 54714 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 371375 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.